Apremilast (Otezla)

Apremilast (Otezla) for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers

Synopsis version of study 

 

https://www.ncbi.nlm.nih.gov/pubmed/30451329/

 

Full version of study

 

https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.15354

Get Updates

Affiliated With

© 2020 by HS Connect   |  HSConnect.org@gmail.com  |  PO Box 73244 Puyallup, WA 98373  |  253.256.1579